1. Home
  2. CLOV vs FTRE Comparison

CLOV vs FTRE Comparison

Compare CLOV & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clover Health Investments Corp.

CLOV

Clover Health Investments Corp.

HOLD

Current Price

$2.58

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.93

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLOV
FTRE
Founded
2014
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CLOV
FTRE
Price
$2.58
$17.93
Analyst Decision
Strong Buy
Hold
Analyst Count
3
8
Target Price
$4.23
$12.64
AVG Volume (30 Days)
4.3M
1.6M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,773,564,000.00
$2,759,900,000.00
Revenue This Year
$41.68
$3.17
Revenue Next Year
$37.69
$0.04
P/E Ratio
N/A
N/A
Revenue Growth
32.15
1.88
52 Week Low
$2.12
$3.97
52 Week High
$4.87
$20.26

Technical Indicators

Market Signals
Indicator
CLOV
FTRE
Relative Strength Index (RSI) 47.32 80.60
Support Level $2.41 $15.55
Resistance Level $2.74 $16.42
Average True Range (ATR) 0.10 1.13
MACD 0.02 0.23
Stochastic Oscillator 36.76 96.29

Price Performance

Historical Comparison
CLOV
FTRE

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: